Big Data – The Right Path Towards Personalized Medicine?
Big Data, captured in electronic medical records or (innovative) diagnostic tools, provide the medical community with a great opportunity to analyze various pathological conditions at an unprecedented depth for many complex diseases.
We are delighted to welcome Prof. Dr. Bernd C. Kieseier, Value Based Medicine, Biogen, Cambridge, MA, USA; Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany
| Date: | 28 March 2018 |
|---|---|
| Time: | 17.00 h to 18.00 h |
| Location: | HS 9 |
Big Data – The Right Path Towards Personalized Medicine?
The possibility to capture an increasing number of descriptions from individuals open new avenues to better understand heterogenous disorders. However, Big Data alone won´t be enough; data curations and analyses need to be designed to deliver highly accurate predicted risk profiles and treatment recommendations. By discussing multiple sclerosis, a heterogenous and complex autoimmune disease affecting the central nervous system, this presentation will discuss the need not only for capturing various data points but also for introducing clinical standards translating data into clinically meaningful information.
Lecture Series Spring 2018: The Patient's Voice in Drug Development
In this lecture series, professionals from industries, adademia and patient organizations will share their visions how the patient perspective can become an integral part of the drug development process, and how this relates to public interests, regulatory requirements, the law and international initiatives.
